96 related articles for article (PubMed ID: 9237063)
1. Histamine-2-receptor antagonists and oesophageal cancer.
Fioretti F; Tavani A; La Vecchia C; Franceschi S
Eur J Cancer Prev; 1997 Apr; 6(2):143-6. PubMed ID: 9237063
[TBL] [Abstract][Full Text] [Related]
2. Histamine-2-receptor antagonists and gastric cancer: update and note on latency and covariates.
La Vecchia C; Negri E; Franceschi S; D'Avanzo B
Nutrition; 1992; 8(3):177-81. PubMed ID: 1356031
[TBL] [Abstract][Full Text] [Related]
3. H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study.
Suleiman UL; Harrison M; Britton A; McPherson K; Bates T
Eur J Cancer Prev; 2000 Jun; 9(3):185-91. PubMed ID: 10954258
[TBL] [Abstract][Full Text] [Related]
4. Cimetidine and other histamine2-receptor antagonist use in relation to risk of breast cancer.
Coogan PF; Zhang Y; Palmer JR; Strom BL; Rosenberg L
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1012-5. PubMed ID: 15824181
[TBL] [Abstract][Full Text] [Related]
5. Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer.
Mathes RW; Malone KE; Daling JR; Porter PL; Li CI
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):67-72. PubMed ID: 18199712
[TBL] [Abstract][Full Text] [Related]
6. Prior immunity-related medical conditions and oesophageal cancer risk: a population-based case-control study in Shanghai.
Dai Q; Zheng W; Ji BT; Shu XO; Jin F; Cheng HX; Gao YT
Eur J Cancer Prev; 1997 Apr; 6(2):152-7. PubMed ID: 9237064
[TBL] [Abstract][Full Text] [Related]
7. Cimetidine use and risk of prostate and breast cancer.
Rossing MA; Scholes D; Cushing-Haugen KL; Voigt LF
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):319-23. PubMed ID: 10750671
[TBL] [Abstract][Full Text] [Related]
8. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
9. Attributable risks for kidney cancer in northern Italy.
Tavani A; Pregnolato A; Violante A; La Vecchia C; Negri E
Eur J Cancer Prev; 1997 Apr; 6(2):195-9. PubMed ID: 9237070
[TBL] [Abstract][Full Text] [Related]
10. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus and the risk of prostate cancer in Italy.
Tavani A; Gallus S; Bertuzzi M; Dal Maso L; Zucchetto A; Negri E; Franceschi S; Ramazzotti V; Montella M; La Vecchia C
Eur Urol; 2005 Mar; 47(3):313-7; discussion 317. PubMed ID: 15716192
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
Nagel G; Linseisen J; Boshuizen HC; Pera G; Del Giudice G; Westert GP; Bueno-de-Mesquita HB; Allen NE; Key TJ; Numans ME; Peeters PH; Sieri S; Siman H; Berglund G; Hallmans G; Stenling R; Martinez C; Arriola L; Barricarte A; Chirlaque MD; Quiros JR; Vineis P; Masala G; Palli D; Panico S; Tumino R; Bingham S; Boeing H; Bergmann MM; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Olsen A; Tjonneland A; Trichopoulou A; Bamia C; Soukara S; Sabourin JC; Carneiro F; Slimani N; Jenab M; Norat T; Riboli E; González CA
Int J Epidemiol; 2007 Feb; 36(1):66-76. PubMed ID: 17227779
[TBL] [Abstract][Full Text] [Related]
14. Histamine-2-receptor antagonists and gastric cancer risk.
La Vecchia C; Negri E; D'Avanzo B; Franceschi S
Lancet; 1990 Aug; 336(8711):355-7. PubMed ID: 1975342
[TBL] [Abstract][Full Text] [Related]
15. Cimetidine use and the risk for prostate cancer: results from the VITAL cohort study.
Velicer CM; Dublin S; White E
Ann Epidemiol; 2006 Dec; 16(12):895-900. PubMed ID: 16843010
[TBL] [Abstract][Full Text] [Related]
16. Recurrent parotitis with H2 receptor antagonists in a patient with Sjogren's syndrome.
Tomasko MA; Luskin AT
Am J Med; 1988 Aug; 85(2):271. PubMed ID: 2899973
[No Abstract] [Full Text] [Related]
17. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
[TBL] [Abstract][Full Text] [Related]
18. Giant gastric ulcer: its natural history and outcome in the H2RA era.
Raju GS; Bardhan KD; Royston C; Beresford J
Am J Gastroenterol; 1999 Dec; 94(12):3478-86. PubMed ID: 10606307
[TBL] [Abstract][Full Text] [Related]
19. H(2) antagonist-induced thrombocytopenia: is this a real phenomenon?
Wade EE; Rebuck JA; Healey MA; Rogers FB
Intensive Care Med; 2002 Apr; 28(4):459-65. PubMed ID: 11967601
[TBL] [Abstract][Full Text] [Related]
20. [The H2-antagonist therapy withdrawal syndrome: the possible role of hyperprolactinemia].
Rampello L; Nicoletti G
Medicina (Firenze); 1990; 10(3):294-6. PubMed ID: 1981922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
